Efficacy, Pharmacokinetics, Tolerability, Safety of SB012 Intrarectally Applied in Active Ulcerative Colitis Patients
Clinical trial NCT02129439 · COMPLETED
Trial details
- NCT number
- NCT02129439
- Sponsor
- Sterna Biologicals GmbH & Co. KG
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-04-01
- Primary completion
- 2017-06-22
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.